Alector logo

Alector Share Price (NASDAQ: ALEC)

$2.15

-0.1

(-4.44%)

Live

Last updated on

Check the interactive Alector Stock chart to analyse performance

Alector stock performance

as on August 19, 2025 at 1:29 AM IST

  • Today's Low:$2.13
    Today's High:$2.31

    Day's Volatility :7.79%

  • 52 Weeks Low:$0.87
    52 Weeks High:$6.37

    52 Weeks Volatility :86.34%

Alector Stock Returns

PeriodAlector IncSector (Health Care)Index (Russel 2000)
3 Months
77.17%
2.3%
0.0%
6 Months
27.84%
-5.8%
0.0%
1 Year
-57.06%
-10.9%
0.0%
3 Years
-80.62%
2.8%
-11.6%

Alector Inc Key Stats

Check Alector key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.25
Open
$2.13
Today's High
$2.31
Today's Low
$2.1
Market Capitalization
$227.7M
Today's Volume
$1.6M
52 Week High
$6.37
52 Week Low
$0.87
Revenue TTM
$81.1M
EBITDA
$-126.4M
Earnings Per Share (EPS)
$-1.16
Profit Margin
-142.1%
Quarterly Earnings Growth YOY
-0.86%
Return On Equity TTM
-103.99%

Stock Returns calculator for Alector Stock including INR - Dollar returns

The Alector stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alector investment value today

Current value as on today

₹45,104

Returns

₹54,896

(-54.9%)

Returns from Alector Stock

₹58,969 (-58.97%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Alector Stock

100%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Alector Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Alector Inc

  • Name

    Holdings %

  • FMR Inc

    14.22%

  • RA Capital Management, LLC

    9.58%

  • BlackRock Inc

    8.18%

  • Vanguard Group Inc

    5.92%

  • T. Rowe Price Associates, Inc.

    4.82%

  • Merck & Co Inc

    3.50%

Analyst Recommendation on Alector Stock

Rating
Trend

Buy

    76%Buy

    17%Hold

    5%Sell

Based on 17 Wall street analysts offering stock ratings for Alector(by analysts ranked 0 to 5 stars)

Alector Share Price Target

What analysts predicted

Upside of 109.7%

Target:

$4.51

Current:

$2.15

Alector share price target is $4.51, a slight Upside of 109.7% compared to current price of $2.15 as per analysts' prediction.

Alector Stock Insights

  • Price Movement

    In the last 1 month, ALEC stock has moved up by 41.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 3.67M → 7.87M (in $), with an average increase of 53.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -40.47M → -30.52M (in $), with an average increase of 32.6% per quarter
  • ALEC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 123.6%
  • ALEC vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 182.0%
  • Price to Sales

    ForALEC every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Alector Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$100.6M
↑ 3.6%
Net Income
$-119.0M
↓ 8.7%
Net Profit Margin
-118.39%
↑ 15.95%

Alector Technicals Summary

Sell

Neutral

Buy

Alector is currently in a neutral trading position according to technical analysis indicators.

Alector Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Alector Inc logo
38.89%
27.84%
-57.06%
-80.62%
-82.69%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Alector Inc

Alector, Inc., a late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases. The company's products under development include Latozinemab (AL001), an investigational human recombinant monoclonal antibody designed to elevate progranulin (PGRN), a protein encoded by the granulin (GRN) gene that regulates lysosomal function, neuronal survival, and inflammation in the brain. Its lead PGRN-elevating candidate is being developed for the potential treatment of frontotemporal dementia with a granulin gene mutation (FTD-GRN) which is caused by heterozygous loss-of-function (LOF) mutations in the GRN gene and results in PGRN haploinsufficiency and is in Phase 3 clinical trial. It also develops AL101/GSK4527226 that is in Phase 2 clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. In addition, the company's preclinical and research pipeline products include ADP037-ABC, a proprietary anti-amyloid beta (Aß) antibody paired with proprietary ABC for the treatment of AD; ADP050-ABC, a GCase replacement therapy paired with proprietary ABC for GBA gene mutation carriers with Parkinson's disease and Lewy body dementia; ADP056, a Reelin modulator designed to block tau pathology and promote synaptic function in AD; and ADP063-ABC and ADP064-ABC that are therapeutic candidates paired with proprietary ABC that target tau pathology in AD through distinct approaches. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including latozinemab and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Organization
Alector
Employees
163
CEO
Dr. Arnon Rosenthal Ph.D.
Industry
Biotechnology

Key Management of Alector Inc

NameTitle
Dr. Arnon Rosenthal Ph.D.
Co-Founder, CEO & Director
Dr. Saraswati Kenkare-Mitra Ph.D.
President and Head of Research & Development
Mr. Neil Berkley M.B.A., M.S.
Interim CFO & Chief Business Officer
Ms. Katie Hogan
Senior Director of Corporate Communication & Investor Relations
Ms. Danielle Pasqualone J.D., Ph.D.
General Counsel
Ms. Clare Hunt M.B.A.
Chief People Officer
Ms. Kristina Cutter M.P.H.
Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer
Ms. Virginia DeJesus-Rueff M.B.A.
Chief of Staff & Head of Strategy
Mr. Giacomo Salvadore M.D.
Chief Medical Officer

Important FAQs about investing in ALEC Stock from India :

What is Alector share price today?

Alector share price today is $2.15 as on . Alector share today touched a day high of $2.31 and a low of $2.13.

What is the 52 week high and 52 week low for Alector share?

Alector share touched a 52 week high of $6.37 and a 52 week low of $0.87. Alector stock price today, is trending at $2.15, lower by 66.25% versus the 52 week high.

How to invest in Alector Stock (ALEC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alector on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alector Shares that will get you 0.6977 shares as per Alector share price of $2.15 per share as on August 19, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Alector Stock (ALEC) from India?

Indian investors can start investing in Alector (ALEC) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Alector stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Alector share’s latest price of $2.15 as on August 19, 2025 at 1:29 AM IST, you will get 4.6512 shares of Alector. Learn more about fractional shares .

What are the returns that Alector has given to Indian investors in the last 5 years?

Alector stock has given -82.69% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?